Focus on monitoring the drug catalog nationwide landing

to focus on monitoring drug catalogs nationwide landing - the State Council requires all provinces by the end of December to develop a key monitoring drug catalog.▍ Focus on Monitoring the National Landing of the Drug Catalog Recently, the State Council issued the Notice of the Leading Group of the State Council on Deepening the Reform of the Medical and Health System on Further Promoting the Experience of Deepening the Reform of the Medical and Health System in Fujian Province and Sanming City (hereinafter referred to as the Notice).According to the State Council's Notice, all provinces have until the end of December to formulate a provincial-level list of key monitoring drugs (chemicals and biological products).The Notice calls for strengthening the supervision and management of medical institutions, monitoring the growth of hospital operations, outpatient and inpatient costs, antimicrobial drugs and auxiliary drug use, and increasing the notification and disclosure of unreasonable drug use.The Notice makes it clear that by the end of December 2019, provinces should formulate a provincial-level list of key drugs for rational drug use (chemicals and biological products) and publish them, and establish a comprehensive monitoring mechanism for key drugs by the end of December 2020.At the same time, all localities should strengthen the management and standardization of drug catalogues of medical institutions, guide and promote the timely adjustment and optimization of drug use catalogues at all levels of various medical institutions, and promote rational drug use.▍Regulated catalog of large probability continues to expand Kangmei PharmaceuticalSOTC Division General Manager Li Cong selected to say that the latest drug management law can be said to be the most stringent in history, many of the penalties are not capped, from this point of view, the next step of drug supervision will certainly be strengthened, the focus on monitoring the scope of the drug catalog will be expanded, Chinese medicine will also be included.The current situation of the Chinese medicine industry is that some Chinese medicine lack of barriers to access, whether it is a real estate area, medicinal herbs are being planted, a large number of Chinese medicine plant construction and put into operation, there is disorderly competition, the phenomenon of bad currency expulsion of good currency, Li Cong said to Sai Bailan.Li said that the focus on monitoring the scope of drug catalog will be expanded, management will be more and more stringent, because the relevant departments must ensure the safety of drug use.Another well-known domestic comprehensive pharmaceutical companies, who did not want to be named, said in an exchange with SaibaiLan, the relevant state departments are expected to introduce a second focus on monitoring drug catalog, the relevant departments will be round by round of key monitoring drugs management.A few days ago, at the scene of a meeting, Seber blue also learned from the authority in the field of drug supervision, according to his judgment, the country's drug supervision in a thorough turn, not to industrial development as the center, but to people's health as the center. He cautions that some products with unclear efficacy need to be prepared and may face a greater regulatory storm.▍ Focus Monitoring System needs supporting measures the focus on the monitoring catalog has a big impact on related drugs - according to the industry sources, who did not want to be named, his company has a variety due to the catalog, sales fell by 50%.He further said that, in fact, before the introduction of the national version of the catalog, the provinces have auxiliary drug use (focus monitoring) catalog, some drug use has been stopped. In addition, many new drugs are also on the market, even if the state does not limit the use of these drugs, their markets will be affected.However, he also pointed out that the current policy measures mainly point to pharmaceutical enterprises and corresponding varieties, although the product structure has improved, there is a certain role of cage-for-bird, but some temporarily non-focused monitoring of drugs in sales and rise.The establishment direction of the key monitoring system is good, but the effect is a long-term process, but also to the hospital internal break-out mechanism and other measures linked.In the end, he also said to Seberan, in fact, in the face of the focus on monitoring the drug catalog, the enterprise as a whole is relatively passive, although concerned, but can not do anything, can only let it go, and finally may have to choose to give up this variety, pharmaceutical companies can only try to promote the time, pay attention to the rationality of hospital medication. (Cypress Blue)